SIRT5 inhibition significantly hampered breast cancer cell invasion and proliferation in high-glucose conditions [131], suppressed malignant transformation, and hindered lung metastasis in the MMTV-PyMT mouse model [132]. The gene discussed is SIRT5; the disease is breast carcinoma.